Today’s top gainers include the company AstraZeneca PLC (NYSE:AZN) which is in the industry Drug Manufacturers – Major, gaining 0.52% today. In the last week its performance is 0.03%, and 22.06% for the past quarter. Currently, AstraZeneca PLC, AZN has a target price of 34.88, so today’s gain of 0.52% is a significant step towards its target price. The GAP today is therefore 1.90%.
AstraZeneca PLC (NYSE:AZN), has a market cap of 86779, and is based in United Kingdom. Insider ownership is at 0.50%, and institutional ownership is 11.00%.
At the current price of 34.48, it has a dividend yield of 5.54%, and its target price is 34.88. This is with a profit margin of 9.00%, and total debt/equity of 1.3. AstraZeneca PLC (NYSE:AZN) has a P/E of 29.7, as well as a forward P/E of 15.24.
With a current EPS of 1.16, and a forecasted EPS growth for next year at -4.50%,AstraZeneca PLC (NYSE:AZN) has had a EPS growth for the past five years at -16.70%. For the next five years EPS growth is projected to be -1.00%.
Performance for the year is 3.89%. Since its IPO date on 5/17/1993, the total performance to date is 4.30%.
Volume today for AstraZeneca PLC (NYSE:AZN), is 6765060, while its average volume is 5839.34. Whilst the total gain today was 0.52%, it did have a day high of 0.06%.
Volatility for this week has been at 1.61%, and 1.59% for the month. The 52-week low for AstraZeneca PLC, AZN has been 27.85%, while the 52-week-high has reached 0.06%.
Looking at its return of investments, which is 11.50%, and its return on assets is 3.70%. AstraZeneca PLC (NYSE:AZN) has an operating margin of 14.50%. With a sales growth of -11.20% quarter over quarter. Bearing in mind that AstraZeneca PLC, AZN is in the sector Healthcare, its long-term debt/equity is 1.22, and has a current ratio of 0.9 and 0.8 for quick ratio.
So what is the value of AstraZeneca PLC? Well its PEG is *TBA, and the P/S is 3.5, along with a P/B of 6.41. Meanwhile it has a p/cash of 18.68.